News

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and ...
Takeda Pharmaceutical named Julie Kim, who heads its U.S. business, as its new chief executive starting in 2026, elevating her to the small but growing ranks of women leading Japanese companies.